| 0 |
Estrogen Receptor Antagonist [EPC] |
167 |
0.0041 |
| 1 |
Aromatase Inhibitor [EPC] |
218 |
0.0019 |
| 2 |
Microtubule Inhibitor [EPC] |
99 |
0.0006 |
| 3 |
Nucleoside Metabolic Inhibitor [EPC] |
127 |
0.0005 |
| 4 |
RANK Ligand Inhibitor [EPC] |
76 |
0.0004 |
| 5 |
Kinase Inhibitor [EPC] |
154 |
0.0003 |
| 6 |
HER2/neu Receptor Antagonist [EPC] |
18 |
0.0002 |
| 7 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
8 |
0.0002 |
| 8 |
Platinum-based Drug [EPC] |
43 |
0.0002 |
| 9 |
Alkylating Drug [EPC] |
35 |
0.0001 |
| 10 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
26 |
0.0001 |
| 11 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
2 |
0.0001 |
| 12 |
Serotonin-3 Receptor Antagonist [EPC] |
7 |
0.0001 |
| 13 |
Non-Standardized Food Allergenic Extract [EPC] |
4 |
0.0001 |
| 14 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
4 |
0.0000 |
| 15 |
Methylxanthine [EPC] |
2 |
0.0000 |
| 16 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 17 |
Nucleoside Analog Antiviral [EPC] |
2 |
0.0000 |
| 18 |
Central Nervous System Stimulant [EPC] |
2 |
0.0000 |
| 19 |
alpha-Adrenergic Blocker [EPC] |
3 |
0.0000 |
| 20 |
Expectorant [EPC] |
4 |
0.0000 |
| 21 |
Central alpha-2 Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 22 |
Benzodiazepine [EPC] |
11 |
0.0000 |
| 23 |
Androgen Receptor Inhibitor [EPC] |
1 |
0.0000 |
| 24 |
beta-Adrenergic Blocker [EPC] |
4 |
0.0000 |
| 25 |
Estrogen [EPC] |
2 |
0.0000 |
| 26 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 27 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
1 |
0.0000 |
| 28 |
HMG-CoA Reductase Inhibitor [EPC] |
2 |
0.0000 |
| 29 |
Thiazide Diuretic [EPC] |
1 |
0.0000 |
| 30 |
Opioid Agonist [EPC] |
1 |
0.0000 |
| 31 |
Platelet Aggregation Inhibitor [EPC] |
2 |
0.0000 |
| 32 |
Corticosteroid [EPC] |
3 |
0.0000 |
| 33 |
Folate Analog Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
2 |
0.0000 |